Register Interest in Lung Test
Research
In conjunction with Nottingham University, Oncimmune® has research programs to develop products for the early detection of the following cancers:
- Lung Cancer
- Breast Cancer
- Ovarian Cancer
- Liver Cancer
- Prostate Cancer
- Pancreatic Cancer
- Colorectal Cancer, including polyp differentiation
The Centre of Excellence for Autoimmunity in Cancer (CEAC) at the University of Nottingham (UK), led by Professor John Robertson, is a "not for profit" academic centre of excellence that has been granted unique access to Oncimmune®'s technology. CEAC will collaborate with academic institutions to research into early stage cancer.
To drive forward this type of investigative research CEAC will be funded by grant, charitable and private funding in addition to that already committed by Oncimmune® and the University of Nottingham. If you are interested in any further information on CEAC, including becoming a partner, please contact us.